(Northern District of California). Represented Medtronic in a patent infringement suit involving Estech’s minimally invasive beating heart surgery devices. Case settled on favorable terms.
(U.S. Patent and Trademark Office). Represented client in major patent interference involving blood screening diagnostic for HIV. The USPTO issued a 122-page opinion in the client’s favor.
(Arbitration) Represented multinational corporation in the medical field in arbitration with potential damages in the nine-figures. A three-arbitrator panel ruled in our client’s favor on every patent; an unusually complete victory for one side in the arbitration context.
(District of Columbia). Represented Celltech in patent litigation involving humanized monoclonal antibodies. Case settled on favorable terms.
(Northern District of California). Represented Impax in two patent litigation matters against Takeda brought under the Hatch-Waxman Act, involving Impax’s proposed generic product for the treatment of acid reflux disease. Prevailed on summary judgment of noninfringement of patent with latest expiration date in the first case, ultimately resulting in cases settling on favorable terms.
(Eastern District of Texas). Represented Alcon and Sandoz in a patent litigation matter brought under the Hatch-Waxman Act, involving glaucoma eye drops. Worked as part of trial team which assumed case from prior counsel who lost first trial, leading to noninfringement verdict after convincing court to order a new trial.